Various preparations of anti-CEA antibodies have shown to detect very sensitively CEA producing tumors. The development of human anti-mouse antibodies (HAMA) prevents from the widespread use of immunoscintigraphy (IS) in the follow-up of patients with colorectal carcinoma. It is, however, not yet clear if genetically reshaped antibodies will solve this problem and it is even less clear if this will change prognosis of these patients. There is certainly room for new therapeutic approaches in colorectal carcinoma. Radioimmunotherapy in combination with other techniques might advantageously complete surgery, chemotherapy and radiotherapy, but needs to be further developed.
GoldenbergD.M., DeLandF.H., KimE.E.Use of radiolabeled antibodies to carcinoembryonic antigen in the detection and localization of diverse cancers by external photoscanning.N Engl J Med1978; 298: 1384–8.
2.
MachJ.P., CarrelS., ForniM., RitschardJ., DonathA., AlbertoP.Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma.N Engl J Med1980; 303: 5–10.
3.
OttR.J., GreyL.J., ZivanovicM.A., FlowerM.A., TrottN.G.The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine-labelled antibodies.Br J Radiol1983; 56: 101–8.
4.
KohlerG., and MilsteinC.Continous cultures of fused cells secreting antibody of predefined specificity.Nature1975; 256: 494–7.
5.
BucheggerF., HaskellC.M., SchreyerM.Radiolabeled fragments of monoclonal antibodies against car-cino-embryonic antigen for localization of human colon carcimona grafted into nude mice.J Exp Med1983; 148: 413–27.
6.
FandI., SharkeyR.M., GrundyJ.P., GoldenbergD.M.Localization by whole-body autoradiography of intact and fragmented radiolabeled antibodies in a metastatic human colonic cancer model.Nucl Med Biol1992; 19: 87–99.
7.
DelaloyeB., Bischof DelaloyeA., BucheggerF.Detection of colorectal carcinoma by emission computerized tomography after injection of 123-1 labeled Fab or F(ab')2 fragments from monoclonal anticarcinoembryonic antibodies.J Clin Invest1986; 77: 301–11.
8.
SerafiniA.N., GoldenbergD.M., Higginbotham-FordE.A.A multicenter trial of cancer imaging with fragments of CEA monocolonal antibodies (Abstract).J Nucl Med1989; 30: 748.
9.
BaumR.P., HertelA., LorenzM., SchwarzA., EnckeA., HörG.99mTc-labeled anti-CEA monoclonal antibody for tumor immunoscintigraphy: first clinical results.Nucl Med Commun1989; 10: 245–52.
10.
MachJ.P., BucheggerF., ForniM.Use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photo-scanning and tomoscintigraphy.Immunol Today1981; 2: 239–49.
11.
Bischof DelaloyeA., PettavelJ., MosimannF., GivelJ.C., DelaloyeB.Premières expériences avec deux anticorps monoclonaux anti-CEA marqués par le Tc-99m et l'In-111 (Abstract).Schweiz med Wschr1989; 119(30): 14.
12.
Bischof DelaloyeA., DelaloyeB., BucheggerF.Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study.J Nucl Med1989; 30: 1646–56.
13.
GaspariniM., CrippaF., RegaliaE., SeregniE., BombardieriE., BuraggiG.L.Role of immunoscintigraphy in local recurrences of colorectal carcinoma: comparison with other diagnostic methods, In: SchmidtH.A.E., BuraggiG.L., eds. Nuclear Medicine.Stuttgart: Schattauer Verlag1989; 515–22.
14.
BaumR.P., LorenzM., Baew-ChristowT.Immunoscintigraphy of colorectal cancer. In: MunzD.L., EmrichD., eds. Immunoscintigraphy: Facts and fiction.Amsterdam: Elsevier Science Publishers BV1990: 95–104.
15.
LindP., LechnerP., Arian-SchadK.Anti-car-cinoembryonic antigen immunoscintigraphy (Techne-tium-99m-monoclonal antibody BW 431/25 and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.J Nucl Med1991; 32: 1319–25.
16.
AprileC., PratiU., SaponaroR., RovedaL., CarenaM., GastaldoL.Radioimmunolocalization of pelvic recurrences from rectosigmoid cancer employing 111In anti-CEA F(ab'2).Nucl Med Biol1991; 18: 51–2.
17.
PinskyC.M., GoldenbergD.M., WlodkowskiT.J., SassoN.L., MojsiakJ.Z., HansenH.J.Detection of occult metastases of colorectal cancer by the use of anti-CEA Fab' fragments labeled with Tc-99m (Abstract).J Nucl Med1991; 32: 1052.
18.
BuraggiG.L., GaspariniM., SeregniE.Immunoscintigraphy of colorectal carcinoma with an anti-CEA monoclonal antibody: a critical review.Nucl Med Biol1991; 18: 45–50.
19.
HardmanN., LeeGillL., De WinterR.F.Generation of a human-mouse chimaeric antibody directed against human carcinoembryonic antigen.Int J Cancer1989; 43: 1188–94.
20.
Bischof DelaloyeA., DelaloyeB., BucheggerF.Prospective immunoscintigraphy (IS) with chimaeric I-123 anti-CEA MAb in patients with rising serum-CEA (Abstract).J Nucl Med1991; 32: 941.
21.
ReynoldsJ.C., Del VecchioS., SakaharaJ.Antimurine antibody response to mouse monoclonal antibodies: clinical findings and implications.Nucl Med Biol1989; 16: 121–5.
22.
HertelA., BaumR.P., AuerbachB., HerrmannA., HörG.Klinische Relevanz humaner Anti-Maus-Antikorper (HAMA) in der Immunszintigraphie.Nucl Med1990; 29: 221–7.
23.
Abdel-NabiH.H., DoerrR.J., ChanH.W.Safety and role of repeated administration of Indium-111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE 025 in the postoperative follow-up of colorectal carcinoma patients.J Nucl Med1992; 33: 14–22.
24.
Bischof DelaloyeA., BucheggerF., MachJ.P.Human anti-mouse response after immunoscintigraphy (IS) with chimeric (ch) anti-CEA monoclonal antibodies (MAb) (Abstract).J Nucl Med1992; 33.
25.
MeredithR.F., KhazaeliM.B., PlottW.E.Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer.J Nucl Med1992; 33: 23–29.
SchlomJ., MilenicD.E., RoselliM.New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinoma.Nucl Med Biol1991; 18: 425–35.
28.
YorkeE.D., BeaumierP.L., WesselsB.W., FritzbergA.R., MorganACJr.Optimal antibody-radionuclide combinations for clinical radioimmunotherapy: a predictive model based on mouse pharmacokinetics.Nucl Med Biol1991; 18: 827–35.
29.
JainR.K.Transport of molecules in the tumor intersti-tium: a review.Cancer Res1987; 47: 3039–51.
30.
BucheggerF., PèlegrinA., DelaloyeB., Bischof DelaloyeA., MachJ.P.Iodine-131 labeled MAb F(ab'2) fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice.J Nucl Med1990; 31: 1035–44.
